{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["angiogenesis", "apoptosis", "breast cancer", "flavonoid", "microRNA", "xanthomicrol"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33217075", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "30"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.6940"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "35", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Apr"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Inhibitory effect of flavonoid xanthomicrol on triple-negative breast tumor via regulation of cancer-associated microRNAs.", "Pagination": {"StartPage": "1967", "EndPage": "1982", "MedlinePgn": "1967-1982"}, "Abstract": {"AbstractText": ["Breast cancer is the leading cause of cancer death in women worldwide. Due to the side effects of current chemo-reagents on healthy tissues, it is essential to search for alternative compounds with less toxicity and better efficacy. In the present study, we have investigated the anticancer effects of flavonoid xanthomicrol on the mice breast cancer model using MTT assay, cell cycle and Annexin/PI analysis, colony formation assay, H&E staining, immunohistochemistry, and miRNA analysis. Our results demonstrated that xanthomicrol decreased the cell viability and clonogenic capability, induced G1-arrest and apoptosis in the breast cancer cells in vitro, and caused a significant reduction in the volume and weight of mice tumors in vivo. In addition, xanthomicrol reduced the expression of TNF\u03b1, VEGF, MMP9, and Ki67, while upregulating the expression of apoptotic markers such as Bax, caspase3, and caspase9. Finally, the expression of miR21, miR27, and miR125, known as oncomirs, decreased significantly after xanthomicrol administration, while the expression of miR29 and miR34, functioning as tumor suppressors, increased significantly (p\u2009<\u2009.001). Our data demonstrated that xanthomicrol can induce apoptosis and suppress angiogenesis in breast cancer cells due to its inhibitory effect on oncomirs and its stimulatory effect on tumor suppressor miRNAs."], "CopyrightInformation": "\u00a9 2020 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0001-8964-2293"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran."}], "LastName": "Attari", "ForeName": "Farnoosh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran."}], "LastName": "Keighobadi", "ForeName": "Faezeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Virology Lab, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran."}], "LastName": "Arefian", "ForeName": "Ehsan", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran."}], "LastName": "Lotfizadeh", "ForeName": "Reza", "Initials": "R"}, {"Identifier": ["0000-0002-1025-3824"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran."}], "LastName": "Sepehri", "ForeName": "Houri", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Moridi Farimani", "ForeName": "Mahdi", "Initials": "M"}], "GrantList": [{"GrantID": "96009946", "Agency": "Iran National Science Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "3IN82Y8CAA", "NameOfSubstance": "xanthomicrol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavones"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Triple Negative Breast Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abbaszadeh, H., Ebrahimi, S. A., & Akhavan, M. M. (2014). Antiangiogenic activity of xanthomicrol and calycopterin, two polymethoxylated hydroxyflavones in both in vitro and ex vivo models. Phytotherapy Research, 28(11), 1661-1670. https://doi.org/10.1002/ptr.5179"}, {"Citation": "Abotaleb, M., Samuel, S. M., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Busselberg, D. (2018). Flavonoids in Cancer and Apoptosis. Cancers (Basel), 11(1). https://doi.org/10.3390/cancers11010028"}, {"Citation": "Amodio, N., Di Martino, M. T., Foresta, U., Leone, E., Lionetti, M., Leotta, M., \u2026 Tassone, P. (2012). miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death & Disease, 3, e436. https://doi.org/10.1038/cddis.2012.175"}, {"Citation": "Andreopoulou, E., Schweber, S. J., Sparano, J. A., & McDaid, H. M. (2015). Therapies for triple negative breast cancer. Expert Opinion on Pharmacotherapy, 16(7), 983-998. https://doi.org/10.1517/14656566.2015.1032246"}, {"Citation": "Chiyomaru, T., Yamamura, S., Fukuhara, S., Yoshino, H., Kinoshita, T., Majid, S., \u2026 Dahiya, R. (2013). Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One, 8(8), e70372. https://doi.org/10.1371/journal.pone.0070372"}, {"Citation": "Chou, J., Lin, J. H., Brenot, A., Kim, J. W., Provot, S., & Werb, Z. (2013). GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nature Cell Biology, 15(2), 201-213. https://doi.org/10.1038/ncb2672"}, {"Citation": "Cook, M. T., Liang, Y., Besch-Williford, C., Goyette, S., Mafuvadze, B., & Hyder, S. M. (2015). Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts. Springerplus, 4, 444. https://doi.org/10.1186/s40064-015-1242-x"}, {"Citation": "Croom, E. (2012). Metabolism of xenobiotics of human environments. Progress in Molecular Biology and Translational Science, 112, 31-88. https://doi.org/10.1016/B978-0-12-415813-9.00003-9"}, {"Citation": "Fan, L., Ma, Y., Liu, Y., Zheng, D., & Huang, G. (2014). Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. European Journal of Pharmacology, 743, 79-88. https://doi.org/10.1016/j.ejphar.2014.09.019"}, {"Citation": "Fattahi, M., Cusido, R. M., Khojasteh, A., Bonfill, M., & Palazon, J. (2014). Xanthomicrol: a comprehensive review of its chemistry, distribution, biosynthesis and pharmacological activity. Mini Reviews in Medicinal Chemistry, 14(9), 725-733."}, {"Citation": "Gao, Y., Liu, F., Fang, L., Cai, R., Zong, C., & Qi, Y. (2014). Genkwanin inhibits proinflammatory mediators mainly through the regulation of miR-101/MKP-1/MAPK pathway in LPS-activated macrophages. PLoS One, 9(5), e96741. https://doi.org/10.1371/journal.pone.0096741"}, {"Citation": "Geng, Y., Chandrasekaran, S., Hsu, J. W., Gidwani, M., Hughes, A. D., & King, M. R. (2013). Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLoS One, 8(1), e54959. https://doi.org/10.1371/journal.pone.0054959"}, {"Citation": "Hollern, D. P., & Andrechek, E. R. (2014). A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer. Breast Cancer Research, 16(3), R59. https://doi.org/10.1186/bcr3672"}, {"Citation": "Hui, C., Qi, X., Qianyong, Z., Xiaoli, P., Jundong, Z., & Mantian, M. (2013). Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One, 8(1), e54318. https://doi.org/10.1371/journal.pone.0054318"}, {"Citation": "Hui, C., Yujie, F., Lijia, Y., Long, Y., Hongxia, X., Yong, Z., \u2026 Mantian, M. (2012). MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis. Breast Cancer Research, 14(3), R80. https://doi.org/10.1186/bcr3194"}, {"Citation": "Jahaniani, F., Ebrahimi, S. A., Rahbar-Roshandel, N., & Mahmoudian, M. (2005). Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry, 66(13), 1581-1592. https://doi.org/10.1016/j.phytochem.2005.04.035"}, {"Citation": "Jodynis-Liebert, J., & Kujawska, M. (2020). Biphasic dose-response induced by phytochemicals: experimental evidence. Journal of Clinical Medicine, 9(3). https://doi.org/10.3390/jcm9030718"}, {"Citation": "Kasem, R. F., Soliman Khater, D., Abdel-Latif, G. A., & Shaker, O. (2018). Expression of miR-34a/p53 and Their Apoptotic Target Bax in Oral Squamous Cell Carcinoma. International Journal of Cancer Research, 14(1), 32-38."}, {"Citation": "Li, G., Yao, L., Zhang, J., Li, X., Dang, S., Zeng, K., \u2026 Gao, F. (2016). Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Tumour Biology, 37(6), 7481-7491. https://doi.org/10.1007/s13277-015-4623-4"}, {"Citation": "Li, S. Z., Hu, Y. Y., Zhao, J., Zhao, Y. B., Sun, J. D., Yang, Y. F., \u2026 Fei, Z. (2014). MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression. Biochemical and Biophysical Research Communications, 444(1), 6-12. https://doi.org/10.1016/j.bbrc.2013.12.136"}, {"Citation": "Li, W., Hao, J., Zhang, L., Cheng, Z., Deng, X., & Shu, G. (2017). Astragalin reduces hexokinase 2 through increasing miR-125b to inhibit the proliferation of hepatocellular carcinoma cells in vitro and in vivo. Journal of Agricultural and Food Chemistry, 65(29), 5961-5972. https://doi.org/10.1021/acs.jafc.7b02120"}, {"Citation": "Li, Y., Kong, D., Wang, Z., & Sarkar, F. H. (2010). Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharmaceutical Research, 27(6), 1027-1041. https://doi.org/10.1007/s11095-010-0105-y"}, {"Citation": "Liu, D., Wang, X., & Chen, Z. (2016). Tumor necrosis factor-alpha, a regulator and therapeutic agent on breast cancer. Current Pharmaceutical Biotechnology, 17(6), 486-494. https://doi.org/10.2174/1389201017666160301102713"}, {"Citation": "Martinez-Perez, C., Ward, C., Turnbull, A. K., Mullen, P., Cook, G., Meehan, J., \u2026 Langdon, S. P. (2016). Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. British Journal of Cancer, 114(8), 905-916. https://doi.org/10.1038/bjc.2016.6"}, {"Citation": "Medina, P. P., Nolde, M., & Slack, F. J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467(7311), 86-90. https://doi.org/10.1038/nature09284"}, {"Citation": "Moradi, M., Gholipour, H., Sepehri, H., Attari, F., Delphi, L., Arefian, E., & Moridi Farimani, M. (2020). Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression. Naunyn-Schmiedeberg's Archives of Pharmacology, 393, 2145-2156. https://doi.org/10.1007/s00210-020-01917-y"}, {"Citation": "Mori, T., Sato, Y., Miyamoto, K., Kobayashi, T., Shimizu, T., Kanagawa, H., \u2026 Miyamoto, T. (2014). TNFalpha promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state. Oncogene, 33(33), 4236-4241. https://doi.org/10.1038/onc.2013.545"}, {"Citation": "Nair, M. P., Mahajan, S., Reynolds, J. L., Aalinkeel, R., Nair, H., Schwartz, S. A., & Kandaswami, C. (2006). The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clinical and Vaccine Immunology, 13(3), 319-328. https://doi.org/10.1128/CVI.13.3.319-328.2006"}, {"Citation": "Peng, Z., & Ying, L. (2014). Effects of TNFalpha on cell viability, proliferation and apoptosis of glioma cells U251. Journal of BUON, 19(3), 733-741."}, {"Citation": "Phuah, N. H., & Nagoor, N. H. (2014). Regulation of microRNAs by natural agents: new strategies in cancer therapies. BioMed Research International, 2014, 804510. https://doi.org/10.1155/2014/804510"}, {"Citation": "Rivera, E., & Cianfrocca, M. (2015). Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemotherapy and Pharmacology, 75(4), 659-670. https://doi.org/10.1007/s00280-014-2607-5"}, {"Citation": "Samec, M., Liskova, A., Kubatka, P., Uramova, S., Zubor, P., Samuel, S. M., \u2026 Busselberg, D. (2019). The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. Journal of Cancer Research and Clinical Oncology, 145(7), 1665-1679. https://doi.org/10.1007/s00432-019-02940-0"}, {"Citation": "Su, K., Tian, Y., Wang, J., Shi, W., Luo, D., Liu, J., \u2026 Wei, L. (2012). HIF-1alpha acts downstream of TNF-alpha to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells. DNA and Cell Biology, 31(6), 1078-1087. https://doi.org/10.1089/dna.2011.1563"}, {"Citation": "Sun, X., & Kaufman, P. D. (2018). Ki-67: more than a proliferation marker. Chromosoma, 127(2), 175-186. https://doi.org/10.1007/s00412-018-0659-8"}, {"Citation": "Szlosarek, P. W., & Balkwill, F. R. (2003). Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. The Lancet Oncology, 4(9), 565-573. https://doi.org/10.1016/s1470-2045(03)01196-3"}, {"Citation": "Tang, F., Zhang, R., He, Y., Zou, M., Guo, L., & Xi, T. (2012). MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One, 7(5), e35435. https://doi.org/10.1371/journal.pone.0035435"}, {"Citation": "Tang, W., Zhu, J., Su, S., Wu, W., Liu, Q., Su, F., & Yu, F. (2012). MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One, 7(12), e51702. https://doi.org/10.1371/journal.pone.0051702"}, {"Citation": "Tao, K., Fang, M., Alroy, J., & Sahagian, G. G. (2008). Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer, 8, 228. https://doi.org/10.1186/1471-2407-8-228"}, {"Citation": "Tao, L., Fu, R., Wang, X., Yao, J., Zhou, Y., Dai, Q., \u2026 Wang, W. (2014). LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G(2)/M phase arrest and cell apoptosis in MCF-7 human breast cancer cells in vitro and in vivo. Toxicology Letters, 228(1), 1-12. https://doi.org/10.1016/j.toxlet.2014.04.002"}, {"Citation": "Vu, L. T., Peng, B., Zhang, D. X., Ma, V., Mathey-Andrews, C. A., Lam, C. K., \u2026 Le, M. T. (2019). Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b. Journal of Extracellular Vesicles, 8(1), 1599680. https://doi.org/10.1080/20013078.2019.1599680"}, {"Citation": "Walle, T. (2007a). Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Seminars in Cancer Biology, 17(5), 354-362. https://doi.org/10.1016/j.semcancer.2007.05.002"}, {"Citation": "Walle, T. (2007b). Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Molecular Pharmaceutics, 4(6), 826-832. https://doi.org/10.1021/mp700071d"}, {"Citation": "Walle, T., Otake, Y., Brubaker, J. A., Walle, U. K., & Halushka, P. V. (2001). Disposition and metabolism of the flavonoid chrysin in normal volunteers. British Journal of Clinical Pharmacology, 51(2), 143-146. https://doi.org/10.1111/j.1365-2125.2001.01317.x"}, {"Citation": "Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., & Luo, H. (2012). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One, 7(4), e34210. https://doi.org/10.1371/journal.pone.0034210"}, {"Citation": "Wang, L. H., Huang, J., Wu, C. R., Huang, L. Y., Cui, J., Xing, Z. Z., & Zhao, C. Y. (2018). Downregulation of miR29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer. Molecular Medicine Reports, 17(2), 2113-2120. https://doi.org/10.3892/mmr.2017.8145"}, {"Citation": "Wen, X., & Walle, T. (2006a). Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metabolism and Disposition, 34(10), 1786-1792. https://doi.org/10.1124/dmd.106.011122"}, {"Citation": "Wen, X., & Walle, T. (2006b). Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica, 36(5), 387-397. https://doi.org/10.1080/00498250600630636"}, {"Citation": "Wolczyk, D., Zaremba-Czogalla, M., Hryniewicz-Jankowska, A., Tabola, R., Grabowski, K., Sikorski, A. F., & Augoff, K. (2016). TNF-alpha promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts. Cellular Oncology (Dordrecht), 39(4), 353-363. https://doi.org/10.1007/s13402-016-0280-x"}, {"Citation": "Wu, J., Sun, Z., Sun, H., & Li, Y. (2018). MicroRNA27a promotes tumorigenesis via targeting AKT in triple negative breast cancer. Molecular Medicine Reports, 17(1), 562-570. https://doi.org/10.3892/mmr.2017.7886"}, {"Citation": "Yin, H., Sun, Y., Wang, X., Park, J., Zhang, Y., Li, M., \u2026 Wei, M. (2015). Progress on the relationship between miR-125 family and tumorigenesis. Experimental Cell Research, 339(2), 252-260. https://doi.org/10.1016/j.yexcr.2015.09.015"}, {"Citation": "Youlden, D. R., Cramb, S. M., Dunn, N. A., Muller, J. M., Pyke, C. M., & Baade, P. D. (2012). The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiology, 36(3), 237-248. https://doi.org/10.1016/j.canep.2012.02.007"}, {"Citation": "Yu, G., Xu, K., Xu, S., Zhang, X., Huang, Q., & Lang, B. (2015). MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao, 35(7), 935-940."}, {"Citation": "Yu, M., Zhou, X., Niu, L., Lin, G., Huang, J., Zhou, W., \u2026 Li, Z. (2013). Targeting transmembrane TNF-alpha suppresses breast cancer growth. Cancer Research, 73(13), 4061-4074. https://doi.org/10.1158/0008-5472.CAN-12-3946"}, {"Citation": "Zadeh, M. M., Motamed, N., Ranji, N., Majidi, M., & Falahi, F. (2016). Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer Cells. Journal of Breast Cancer, 19(1), 45-52. https://doi.org/10.4048/jbc.2016.19.1.45"}, {"Citation": "Zamani, S. S., Hossieni, M., Etebari, M., Salehian, P., & Ebrahimi, S. A. (2016). Pharmacokinetics of calycopterin and xanthmicrol, two polymethoxylated hydroxyflavones with anti-angiogenic activities from Dracocephalum kotschyi Bioss. DARU, 24(1), 22. https://doi.org/10.1186/s40199-016-0161-x"}, {"Citation": "Zheng, Y., Li, S., Boohaker, R. J., Liu, X., Zhu, Y., Zhai, L., \u2026 Fu, L. (2015). A MicroRNA expression signature in taxane-anthracycline-based neoadjuvant chemotherapy response. Journal of Cancer, 6(7), 671-677. https://doi.org/10.7150/jca.11616"}, {"Citation": "Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., \u2026 Tan, M. (2010). MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. The Journal of Biological Chemistry, 285(28), 21496-21507. https://doi.org/10.1074/jbc.M109.083337"}, {"Citation": "Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y. Y. (2008). MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research, 18(3), 350-359. https://doi.org/10.1038/cr.2008.24"}, {"Citation": "Zubor, P., Kubatka, P., Kajo, K., Dankova, Z., Polacek, H., Bielik, T., \u2026 Golubnitschaja, O. (2019). Why the gold standard approach by mammography demands extension by multiomics? Application of liquid biopsy miRNA profiles to breast cancer disease management. International Journal of Molecular Sciences, 20(12). https://doi.org/10.3390/ijms20122878"}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "9", "Day": "12"}, {"Year": "2020", "Month": "5", "Day": "1"}, {"Year": "2020", "Month": "10", "Day": "17"}, {"Year": "2020", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "20", "Hour": "17", "Minute": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33217075", "10.1002/ptr.6940"]}}]}